Primary Record
Q-VD-OPh
- In stock
- 3,746 g
- Purity
- 98.2 %
- CAS
- 1135695-98-5
Compound Identifiers & Properties
- CAS
- 1135695-98-5
- PubChem CID
- 24794416
- SMILES
- CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)COC1=C(C=CC=C1F)F)NC(=O)C2=NC3=CC=CC=C3C=C2
- Canonical SMILES
- CC(C)[C@H](NC(=O)c1ccc2ccccc2n1)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)cccc1F
Names & Synonyms
- Q-VD-OPh
- Q-VD-OPh hydrate
- QVD-OPH
- 1135695-98-5
- Q-Val-Asp-OPH
- Q-VD-(Ome)-OPH
- RefChem:1050302
- C26H25F2N3O6
- DTXSID90647322
- MFCD08669741
- Q-Val-Asp(monomethylated)-Oph
- orb1310761
- CHEMBL4237988
- SCHEMBL15449978
- DTXCID00598073
- CHEBI:232611
- OOBJCYKITXPCNS-REWPJTCUSA-N
- quinoline-val-asp(OMe)-CH2-OPH
- GLXC-21374
- Quinoline-Val-Asp-Difluorophenoxymethylketone
- EX-A1093
- s7311
- ZINC25668329
- AKOS027446655
- BAT-010288
- CCG-269797
- CS-6252
- quinoline-valine-aspartic-CH2-O-phenyl
- AC-31505
- BS-14641
- CID:24794416
- FD103285
- HY-12305
- SID:53786968
- SY269687
- Pan-Caspase Inhibitor (Fluoromethylketone)
- A1901
- J3.189.140J
- A14915
- A903806
- C468548
- (3S)-5-(2,6-Difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-pentanoic Acid
- (S)-5-(2,6-Difluorophenoxy)-3-((S)-3-methyl-2-(quinoline-2-carboxamido)butanamido)-4-oxopentanoic acid
- N-(2-Quinolyl)valyl-aspartyl-(2,6-difluorophenoxy)methyl ketone
- (3S)-5-(2,6-difluorophenoxy)-3-[[(2S)-3-methyl-2-(quinoline-2-carbonylamino)butanoyl]amino]-4-oxopentanoic acid
- N-(2-Quinolinyl)valyl-aspartyl (2,6-difluorophenoxy)methyl ketone
- quinolyl-valyl-O-methylaspartyl-(2,6-difluorophenoxy)methyl ketone
- (3S)-5-(2,6-difluorophenoxy)-3-[[(2S)-3-methyl-2-(quinoline-2-carbonylamino)butanoyl]amino]-4-oxo-pentanoic acid
- 2-[[N-[(2-Quinolinyl)carbonyl]-L-Val-L-Asp-]methoxy]-1,3-difluorobenzene
- pentanoic acid, 5-(2,6-difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-, (3S)-
- (3s)-5-(2,6-difluorophenoxy)-3-((2s)-3-methyl-1-oxo-2-((2-quinolinylcarbonyl)amino)butylamino)-4-oxopentanoic acid
- (3S)-5-(2,6-DIFLUOROPHENOXY)-3-[(2S)-3-METHYL-2-(QUINOLIN-2-YLFORMAMIDO)BUTANAMIDO]-4-OXOPENTANOIC ACID
- (3S)-5-(2,6-difluorophenoxy)-3-[(2S)-3-methyl-2-[(quinolin-2-yl)formamido]butanamido]-4-oxopentanoic acid
- (3S)-5-(2,6-Difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-pentanoic Acid; Pentanoic acid, 5-(2,6-difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-, (3S)-; (3S)-5-(2,6-Difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxopentanoic acid; Q-VD-OPh; N-(2
- (3S)-5-(2,6-Difluorophenoxy)-4-oxo-3-((N-(quinoline-2-carbonyl)-L-valyl)amino)pentanoic acid
- (3S)-5-(2,6-Difluorophenoxy)-4-oxo-3-{[N-(quinoline-2-carbonyl)-L-valyl]amino}pentanoic acid
- (S)-5-(2,6-Difluorophenoxy)-3-[(S)-3-methyl-2-(quinoline-2-carboxamido)butanamido]-4-oxopentanoic Acid